Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
12.09
-6.82 (-36.07%)
At close: Dec 5, 2025, 4:00 PM EST
11.45
-0.64 (-5.29%)
After-hours: Dec 5, 2025, 7:43 PM EST
Quoin Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 10 | 5 | 5 | 7 | 15 | - | |
| Market Cap Growth | 234.78% | 10.02% | -29.65% | -54.69% | - | - | |
| Enterprise Value | 6 | -2 | -5 | -4 | 21 | - | |
| Last Close Price | 18.91 | 22.77 | 171.68 | 596.40 | 9555.01 | - | |
| PB Ratio | - | 0.58 | 0.86 | 0.93 | 23.12 | - | |
| P/TBV Ratio | - | 0.61 | 0.95 | 1.03 | - | - | |
| Debt / Equity Ratio | -2.04 | 0.32 | 0.62 | 0.56 | 7.19 | -0.18 | |
| Quick Ratio | 0.94 | 3.36 | 2.99 | 3.64 | 1.64 | 0.04 | |
| Current Ratio | 1.04 | 3.57 | 3.15 | 3.79 | 1.79 | 0.06 | |
| Return on Equity (ROE) | -651.40% | -120.55% | -132.92% | -232.68% | - | - | |
| Return on Assets (ROA) | -99.47% | -42.72% | -44.03% | -48.59% | -70.60% | -87.18% | |
| Return on Capital (ROIC) | -181.28% | -55.88% | -56.58% | -68.43% | - | - | |
| Return on Capital Employed (ROCE) | -2150.70% | -82.70% | -109.20% | -84.70% | -126.80% | 25.30% | |
| Earnings Yield | -149.18% | -168.23% | -179.39% | -136.30% | -141.27% | - | |
| Buyback Yield / Dilution | -416.87% | -420.43% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.